NYSE · HUN

Huntsman Corporation

$11.74 -$1.06 (-8.28%) 1D After hours

Key Metrics

$2.24B
Market cap
P/E · TTM
$5.69B
Revenue · TTM
−$332.00M
Net income
EPS · TTM $-1.93
Dividend yield 5.3%
Free cash flow $135.00M
Beta · 1Y 1.52
EBITDA · TTM $43.00M
Gross margin 12.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 1
    From its Jun 15 high, the share price fell 34%.

    Peak close $15.89 on Jun 15; trough close $10.55 on Jul 1. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Jun 16
    The stock moved -17.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 16
  • Feb 3
    The stock moved +13.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.24B
Enterprise value$3.93B
Shares outstanding175.4M
52-wk range$7.30 – $16.09
Avg volume · 20D2.9M
Net cash −$1.69B
Book value / share$15.55
IndustryChemicals & Allied Products
ExchangeNYSE
About Huntsman Corporation
IPO dateFeb 11, 2005
Employees6000

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.39
P/FCF16.63
EV/EBITDA91.44
EV/Sales0.69
Graham №

Profitability

Gross 12.9%
Operating -4.4%
Net -5.8%
FCF 2.4%
ROE / ROIC -11.2% · -6.2%

Financial Health

Current ratio1.27
Quick ratio0.75
Debt / equity0.77
Debt / EBITDA 47.81
Net cash −$1.69B
Working capital$460.00M

Cash Flow · TTM

Operating CF $310.00M
Capex −$175.00M
Free cash flow $135.00M
Buybacks
Dividends paid $118.00M
Shareholder yield 5.3%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

1.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings